Congress Coverage: ASH 2020 – Focus on Multiple Myeloma

Expert perspectives on the latest therapeutic developments, treatment approaches, and implications for clinical decision-making regarding multiple myeloma.

December 11, 2020


Rafael Fonseca, MD

Mayo Clinic Phoenix, AZ

Faculty Members

Irene M. Ghobrial, MD
Dana-Farber Cancer Institute, Boston, MA, US

Sagar Lonial, MD, FACP
Winship Cancer Institute, Atlanta, GA, US

Philippe Moreau, MD
University Hospital of Nantes, Nantes, France

Suzanne Lentzsch, MD, PhD
Columbia University Irving Medical Center, New York, NY, US

Keith Stewart, MB, ChB, MBA
Princess Margaret Cancer Centre, Toronto, ON, Canada

Peter Voorhees, MD
Levine Cancer Institute, Charlotte, NC, US

Sample Report

Start discovering the insights

View Report


  • Clinical experts from across the world discussed global perspectives on current treatment strategies and emerging therapies in multiple myeloma derived from ASH 2020 data
  • The goal of the expert panel was to critique and debate new evidence in multiple myeloma and gain strategic insight into the most impactful abstracts from the ASH meeting with respect to shaping current research directions and/or changing the scope of practical clinical care

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.